explore -WSS

explore

author：fashion 2025-08-28 08:40:03 - browse：541

Venture capital firm RA Capital is starting a new incubator, setting the stage for the firm to create new startups over the next several years that hone in on synthetic biology, a long-gestating field that insiders say is getting renewed interest.

The Boston-based VC’s incubator is called RASyn, and will be led by Robert Nicol, according to people familiar with the firm’s plans. Nicol spent more than 20 years at the Broad Institute, where he co-founded the MIT-Broad Foundry for Synthetic Biology, as well as HiFiBio Therapeutics and Design Pharmaceuticals.

RA Capital confirmed RASyn’s existence. Senior Managing Director Josh Resnick told STAT it’s part of the firm’s work to rethink how it develops platforms — core technologies or scientific approaches that underpin all of the drugs a biotech develops — but declined to comment further.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： 'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

knowledge

WSS

Elizabeth Holmes banned from government health programs

An Ebola outbreak presents a new mystery involving children

CDC launches VaccineFinder tool to locate Covid

Think you might have Covid

Zapping the brain for stroke rehab: Pivotal clinical trial begins

Think you might have Covid

Wikipedia

explore

focus

Wildfire smoke exposes gaps in outdoor worker protections

Sage's campaign to raise awareness of postpartum depression hits a nerve

New air purifier tech could be key to improving indoor air quality

New brain studies show LSD's effects on the brain in full color

What does generative AI mean for health care? We asked experts

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Psychedelics group wrestles with new pharma identity

Copay coupons to count toward deductibles, after Biden court move

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden praises World Series champion Astros for impact off the field during White House celebration

hotspot

Discs beat pads, tampons for heavy menstrual flow, new study shows

eGenesis tests gene

How digital therapeutics firms are pivoting after Pear's bankruptcy

Wegovy cuts risk of cardiovascular events by 20%, study finds

Travel bans should be based on evidence, not politics or fear

The surgeon had a dilemma only a Nazi medical text could resolve

knowledge

knowledge

explore

Wikipedia